Litigation Details for CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD. (D.N.J. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD. (D.N.J. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-07-10 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-03-29 |
| Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | None | Referred To | Leda D. Wettre |
| Parties | ALVOGEN PINE BROOK LLC | ||
| Patents | 6,315,720; 6,561,977; 6,755,784; 7,189,740; 7,465,800; 7,855,217; 7,968,569; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 9,056,120; 9,101,621; 9,101,622 | ||
| Attorneys | SARAH ANN SULLIVAN | ||
| Firms | Quinn Emanuel Uquhart & Sullival LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 1 | Complaint | United States Patent Nos. 5,635,517 (the “’517 patent”), 6,315,720 (the “’720 patent”), 6,561,977 (the… patent”), and 8,431,598 (the “’598 patent”), all owned by Celgene (collectively, “the patents-in- …(the “’977 patent”), 6,755,784 (the “’784 patent”), 7,189,740 (the “’740 patent”), 7,465,800 (the “’800…’800 patent”), 7,855,217 (the “’217 patent”), 7,968,569 (the “’569 patent”), 8,315,886 (the “’886 patent…,717 (the “’717 patent”), 8,530,498 (the “’498 patent”), 8,626,531 (the “’531 patent”), 8,648,095 (the | External link to document |
| 2019-03-29 | 40 | Judgment, the term Patents-in-Suit shall mean U.S. Patent Nos. 5.635,517; 6,3 15,720; 6,561,977; 6,755,784; … the term “Patents—in—Suit” shall mean U.S. Patent Nos. 5.635,517; 6,3 15,720; 6,561,977; 6,755,784… 4. Until expiration of the Patents.ineSuit, Lotus, including any of Its successors…parties in connection with any infringement of the Patents-in-Suit by any such third panics in connection…C.F.R. § 31 4.94(a)( 12) with respect to the Patents-in-Suit. 9. Nothing | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
